Drs. Kullo and Kopecky talk about why genetic testing is needed in chronic heart disease (CHD) risk stratification, how does one assess genetic risk for CHD, what is the potential role of polygenetic risk scores (PRSs) in assessing CHD risk and are PRSs currently available and how might these be combined with existing risk calculators.
